secwatch.observer — SEC 8-K summary
======================================

Issuer:     RELMADA THERAPEUTICS, INC. (RLMD)
CIK:        0001553643
Form:       8-K
Filed at:   2023-10-04T23:59:59+00:00
Accession:  0001013762-23-001391
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Relmada Therapeutics updates corporate presentation on October 4, 2023
----------------------------------------------------------------------

- Filed updated corporate presentation under Item 8.01; no financial or pipeline data disclosed.
- Presentation titled 'Targeting Major Advances in the Treatment of CNS Disorders'.
- No material changes or specific business updates provided in the filing or exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1553643/000101376223001391/0001013762-23-001391-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1553643/000101376223001391/ea186313-8k_relmada.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-001391

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer